Healthcare Industry News: Perfexion
News Release - July 11, 2006
Elekta: First Patient Treated with New Leksell Gamma Knife(R) Perfexion(TM)
STOCKHOLM, Sweden--(HSMN NewsFeed)--July 11, 2006--Leksell Gamma Knife® Perfexion(TM), Elekta's (STO:EKTAB) new system for stereotactic radiosurgery, has for the first time been used clinically to treat patients at Hopital de la Timone (University Hospital La Timone) in Marseille, France.Leksell Gamma Knife Perfexion represents a completely new technological approach. Designed for unlimited cranial reach and developed with a strong focus on ease of use and comfort for both patients and staff. This quantum leap provides a radiosurgical platform for further refinement and expansion of procedures in the brain, cervical spine and head & neck regions.
University Hospital La Timone is first in the world to have a Leksell Gamma Knife Perfexion installed and in clinical use. On July 10, three patients were successfully treated.
"We are very proud to be the first clinic in the world to be able to provide stereotactic radiosurgery with Leksell Gamma Knife Perfexion, a highly sophisticated system allowing us to treat more patients. Both patients and staff will benefit from the smart design that will rationalize our work procedures, giving us more time to focus on our patients", comments Professor Jean Regis.
University Hospital La Timone is an internationally well recognized clinic and a Center of Excellence in radiosurgery. Professor Jean Regis has also participated with very valuable expert advice in the development process of Leksell Gamma Knife Perfexion.
"I am very pleased to see that four years of research and development pays off and comes to the benefit of patients, first here in France but also in the future throughout the world with more installation of this truly innovative system", says Tomas Puusepp, President and CEO of Elekta.
Leksell Gamma Knife® Perfexion(TM) is subject to regulatory clearance in North America.
About Elekta
Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.
Clinical solutions include among others Leksell Gamma Knife® for non-invasive treatment of brain disorders and Elekta Synergy® for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group is the world's largest supplier of oncology software.
Elekta's systems and solutions are used at over 3,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.
With approx. 1850 employees, Elekta's corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.
Source: Elekta
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
